Transforming growth factor‐β, matrix metalloproteinases, and urokinase‐type plasminogen activator interaction in the cancer epithelial to mesenchymal transition

JF Santibanez, H Obradović, T Kukolj… - Developmental …, 2018 - Wiley Online Library
Transforming growth factor‐β (TGF‐β) is a pleiotropic factor that acts as a tumor suppressor
in the early stages, while it exerts tumor promoting activities in advanced stages of cancer …

Role of serine proteases at the tumor-stroma interface

R Tagirasa, E Yoo - Frontiers in immunology, 2022 - frontiersin.org
During tumor development, invasion and metastasis, the intimate interaction between tumor
and stroma shapes the tumor microenvironment and dictates the fate of tumor cells. Stromal …

TGF-β1 acts through miR-155 to down-regulate TP53INP1 in promoting epithelial–mesenchymal transition and cancer stem cell phenotypes

F Liu, X Kong, L Lv, J Gao - Cancer letters, 2015 - Elsevier
It has been shown that acquisition of epithelial–mesenchymal transition (EMT) and induction
of cancer stem cell (CSC)-like properties contribute to metastasis of cancers in many studies; …

Hyperactivation of MAPK induces tamoxifen resistance in SPRED2-deficient ERα-positive breast cancer

V Vafeiadou, D Hany, D Picard - Cancers, 2022 - mdpi.com
Simple Summary Tamoxifen has been used for more than 40 years to treat breast tumors
that are dependent on the hormone estrogen for their growth. However, resistance and …

Spred2: A novel regulator of epithelial-mesenchymal transition and stemness in hepatocellular carcinoma cells

T Gao, X Yang, M Fujisawa, T Ohara, T Wang… - International journal of …, 2023 - mdpi.com
The downregulation of SPRED2, a negative regulator of the ERK1/2 pathway, was
previously detected in human cancers; however, the biological consequence remains …

Enhancer variants on chromosome 2p14 regulating SPRED2 and ACTR2 act as a signal amplifier to protect against rheumatoid arthritis

NN Wang, Y Zhang, F Jiang, DL Zhu, CX Di… - The American Journal of …, 2023 - cell.com
Genome-wide association studies (GWASs) have repeatedly reported multiple non-coding
single-nucleotide polymorphisms (SNPs) at 2p14 associated with rheumatoid arthritis (RA) …

Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial–mesenchymal transition and endothelial injury by suppressing …

T Liu, J Zhao, C Lin - Bioengineered, 2022 - Taylor & Francis
Diabetic retinopathy (DR) is a common complication of diabetes, and the leading cause of
blindness in adults. Sprouty-related proteins with EVH1 domain (SPRED2) play an important …

Remodeling of the extracellular matrix by serine proteases as a prerequisite for cancer initiation and progression

T Wenta, P Nastaly, B Lipinska, A Manninen - Matrix Biology, 2024 - Elsevier
The extracellular matrix (ECM) serves as a physical scaffold for tissues that is composed of
structural proteins such as laminins, collagens, proteoglycans and fibronectin, forming a …

Spred2 inhibits epithelial‑mesenchymal transition of colorectal cancer cells by impairing ERK signaling

H Wang, S Liu, F Kong, F Xiao, Y Li… - Oncology …, 2020 - spandidos-publications.com
Downregulation of the sprouty‑related EVH1 domain protein 2 (Spred2) is closely
associated with highly metastatic phenotypes in various tumors. However, the roles of …

[HTML][HTML] SMAD3 is essential for transforming growth factor-β1-induced urokinase type plasminogen activator expression and migration in transformed keratinocytes

J Kocic, D Bugarski, JF Santibanez - European journal of cancer, 2012 - Elsevier
Transforming growth factor-β1 (TGF-β1) stimulates the extracellular matrix degrading
proteases expression and cell migration in order to enhance cancer cells malignancy. In the …